Secobarbital

Secobarbital sodium (marketed by Eli Lilly and Company, and subsequently by other companies as described below, under the brand name Seconal) is a barbiturate derivative drug that was patented in 1934 in the US. It possesses anaesthetic, anticonvulsant, sedative, and hypnotic properties. In the United Kingdom, it was known as Quinalbarbitone.